Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orphan Designation Requests To Get Slower Reviews

11 May 2016

• By Derrick Gingery

Related Content

Targeted Therapies On FDA’s Orphan Designation Radar

29 Apr 2013

The Good Old Days: FDA's Jenkins Instructs Reviewers To Meet Original User Fee Review Time Standard

07 Dec 2009

Priority Review Vouchers Could Be Used Frequently Next Year

04 Feb 2015

'Cures' vs Funding: FDA Appropriations Bill Is Latest Battleground

25 Apr 2016

Related Companies

Assertio Holdings, Inc.

Eagle Pharmaceuticals, Inc.

Additional Topics

United States Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.